MACM
March Altus Capital Management Portfolio holdings
AUM
$16M
This Quarter Return
+16.24%
1 Year Return
+18.92%
3 Year Return
+153.93%
5 Year Return
–
10 Year Return
–
AUM
$15.9M
AUM Growth
+$15.9M
(-93%)
Cap. Flow
-$216M
Cap. Flow
% of AUM
-1,356.2%
Top 10 Holdings %
Top 10 Hldgs %
77.88%
Holding
25
New
3
Increased
–
Reduced
12
Closed
10
Top Buys
| 1 |
THOR
THORATEC CORPORATION
THOR
|
$1.04M |
| 2 |
Cencora
COR
|
$764K |
| 3 |
Labcorp
LH
|
$723K |
Top Sells
| 1 |
United Therapeutics
UTHR
|
$18M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$17.3M |
| 3 |
DexCom
DXCM
|
$15.6M |
| 4 |
Amgen
AMGN
|
$12.8M |
| 5 |
Universal Health Services
UHS
|
$12.6M |
Sector Composition
| 1 | Healthcare | 78.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$17.7B
| $1.86M | 11.72% |
10,808
-104,269
| -91% | -$18M |
|
|
2
Universal Health Services
UHS
$11.6B
| $1.82M | 11.44% |
15,453
-107,451
| -87% | -$12.6M |
|
|
CYNO
3
DELISTED
Cynosure, Inc. Class A
CYNO
| $1.34M | 8.43% |
43,729
-271,988
| -86% | -$8.34M |
|
4
Humana
HUM
$37.5B
| $1.14M | 7.17% |
6,403
-55,178
| -90% | -$9.82M |
|
|
MNK
5
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $1.08M | 6.8% |
8,540
-136,531
| -94% | -$17.3M |
|
6
Regeneron Pharmaceuticals
REGN
$59.8B
| $1.08M | 6.79% |
2,392
-27,228
| -92% | -$12.3M |
|
|
THOR
7
DELISTED
THORATEC CORPORATION
THOR
| $1.04M | 6.52% |
+24,765
| New | +$1.04M |
|
8
Eli Lilly
LLY
$661B
| $1.03M | 6.48% |
14,192
-141,225
| -91% | -$10.3M |
|
|
9
DexCom
DXCM
$30.9B
| $1.02M | 6.4% |
16,332
-250,744
| -94% | -$15.6M |
|
|
MDCO
10
DELISTED
Medicines Co
MDCO
| $974K | 6.12% |
34,744
-401,242
| -92% | -$11.2M |
|
|
11
Cencora
COR
$57.2B
| $764K | 4.8% |
+6,717
| New | +$764K |
|
|
12
Labcorp
LH
$22.8B
| $723K | 4.55% |
+5,735
| New | +$723K |
|
13
Incyte
INCY
$17B
| $710K | 4.46% |
7,742
-41,475
| -84% | -$3.8M |
|
14
Zoetis
ZTS
$67.6B
| $683K | 4.29% |
14,747
-91,075
| -86% | -$4.22M |
|
|
ALXN
15
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $638K | 4.01% |
3,680
-62,280
| -94% | -$10.8M |
|
|
UAM
16
DELISTED
Universal American Corp
UAM
| – | – |
-1,128,043
| Closed | -$10.5M |
|
|
ENZY
17
DELISTED
Enzymotec Ltd
ENZY
| – | – |
-681,778
| Closed | -$5.13M |
|
|
WCG
18
DELISTED
Wellcare Health Plans, Inc.
WCG
| – | – |
-117,823
| Closed | -$9.67M |
|
|
AMAG
19
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| – | – |
-113,079
| Closed | -$4.82M |
|
20
West Pharmaceutical
WST
$17.9B
| – | – |
-210,910
| Closed | -$11.2M |
|
21
Select Medical
SEM
$1.6B
| – | – |
-543,455
| Closed | -$7.83M |
|
22
Encompass Health
EHC
$12.5B
| – | – |
-107,885
| Closed | -$4.15M |
|
|
AVDL
23
Avadel Pharmaceuticals
AVDL
$1.42B
| – | – |
-394,897
| Closed | -$6.77M |
|
|
24
Amgen
AMGN
$153B
| – | – |
-80,600
| Closed | -$12.8M |
|
25
Align Technology
ALGN
$9.59B
| – | – |
-196,368
| Closed | -$11M |
|